These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11361746)

  • 21. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.
    DiNunzio JC; Hughey JR; Brough C; Miller DA; Williams RO; McGinity JW
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1064-78. PubMed ID: 20334539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.
    Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1862-5. PubMed ID: 9661037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacokinetic model of the gastrointestinal tract consisting of two segments can describe the concentration-time course of itraconazole.
    Lohitnavy M; Lu Y; Lohitnavy O
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):394-6. PubMed ID: 16961171
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of compounding on pharmacokinetics of itraconazole in black-footed penguins (Spheniscus demersus).
    Smith JA; Papich MG; Russell G; Mitchell MA
    J Zoo Wildl Med; 2010 Sep; 41(3):487-95. PubMed ID: 20945648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose and multiple dose studies of itraconazole nanoparticles.
    Vaughn JM; McConville JT; Burgess D; Peters JI; Johnston KP; Talbert RL; Williams RO
    Eur J Pharm Biopharm; 2006 Jun; 63(2):95-102. PubMed ID: 16516450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator-Formulated Itraconazole Capsules and Solution in Healthy Dogs.
    Hasbach AE; Langlois DK; Rosser EJ; Papich MG
    J Vet Intern Med; 2017 Jul; 31(4):1163-1169. PubMed ID: 28627123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of in vivo-in vitro correlation in per-oral drug delivery.
    Park K
    J Control Release; 2014 Apr; 180():150. PubMed ID: 24679518
    [No Abstract]   [Full Text] [Related]  

  • 29. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum itraconazole concentrations and clinical responses in Candida-associated denture stomatitis patients treated with itraconazole solution and itraconazole capsules.
    Cross LJ; Bagg J; Oliver D; Warnock D
    J Antimicrob Chemother; 2000 Jan; 45(1):95-9. PubMed ID: 10629018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
    Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Author's reply.
    Ardeshna KP; Rohatgi S; Jerajani HR
    Indian J Dermatol Venereol Leprol; 2017; 83(1):69-70. PubMed ID: 27917843
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.
    Mouton JW; van Peer A; de Beule K; Van Vliet A; Donnelly JP; Soons PA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4096-102. PubMed ID: 16982783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
    Lee JH; Shin JH; Lee MG
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis.
    Conway SP; Etherington C; Peckham DG; Brownlee KG; Whitehead A; Cunliffe H
    J Antimicrob Chemother; 2004 May; 53(5):841-7. PubMed ID: 15044430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption, first-pass metabolism, and disposition of itraconazole in rats.
    Yoo SD; Kang E; Jun H; Shin BS; Lee KC; Lee KH
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):798-801. PubMed ID: 10866139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat.
    Rabinow B; Kipp J; Papadopoulos P; Wong J; Glosson J; Gass J; Sun CS; Wielgos T; White R; Cook C; Barker K; Wood K
    Int J Pharm; 2007 Jul; 339(1-2):251-60. PubMed ID: 17398045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and tissue distribution of itraconazole after oral and intravenous administration to horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2005 Oct; 66(10):1694-701. PubMed ID: 16273899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).
    Tell LA; Craigmill AL; Clemons KV; Sun Y; Laizure SC; Clifford A; Ina JH; Nugent-Deal JP; Woods L; Stevens DA
    J Vet Pharmacol Ther; 2005 Jun; 28(3):267-74. PubMed ID: 15953200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.